Taysha Gene Therapies Inc Inc. (TSHA) Price Performance: A Technical Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -27.88%. However, over the last six months, the performance has been weaker by 120.42%. The price of TSHA decreased -21.26% over the last 30 days. And in the last five days, it has surged by 8.31%.

Taysha Gene Therapies Inc (TSHA) current stock price is $1.63. During the last trading session, the stock soared, reaching $1.72 after opening at $1.66. The stock’s lowest point was $1.515 before it closed at $1.57.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Taysha Gene Therapies Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $3.89 on 09/05/23, and the lowest price during that time was $0.50, recorded on 06/26/23.

52-week price history of TSHA Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Taysha Gene Therapies Inc’s current trading price is -58.10% away from its 52-week high, while its distance from the 52-week low is 226.00%. The stock’s price range for this period has been between $0.50 and $3.89. The Healthcare sector company’s shares saw a trading volume of about 0.75 million for the day, which was lower than the average daily volume of 2.81 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Taysha Gene Therapies Inc (TSHA) has experienced a quarterly decline of -15.10% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 304.74M and boasts a workforce of 65 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9653, with a change in price of +1.0000. Similarly, Taysha Gene Therapies Inc recorded 3,926,504 in trading volume during the last 100 days, posting a change of +169.49%.

TSHA Stock Stochastic Average

As of today, the raw stochastic average of Taysha Gene Therapies Inc over the past 50 days is 12.92%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 21.62%. Additionally, the Stochastic %K and %D values for the company were 23.20% and 17.12%, respectively, over the past 20 days.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts